1. Home
  2. IMUX vs SHIM Comparison

IMUX vs SHIM Comparison

Compare IMUX & SHIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMUX
  • SHIM
  • Stock Information
  • Founded
  • IMUX 2016
  • SHIM 1990
  • Country
  • IMUX United States
  • SHIM United States
  • Employees
  • IMUX N/A
  • SHIM N/A
  • Industry
  • IMUX Biotechnology: Pharmaceutical Preparations
  • SHIM
  • Sector
  • IMUX Health Care
  • SHIM
  • Exchange
  • IMUX Nasdaq
  • SHIM Nasdaq
  • Market Cap
  • IMUX 92.2M
  • SHIM 97.5M
  • IPO Year
  • IMUX N/A
  • SHIM 2023
  • Fundamental
  • Price
  • IMUX $0.76
  • SHIM $2.15
  • Analyst Decision
  • IMUX Strong Buy
  • SHIM
  • Analyst Count
  • IMUX 5
  • SHIM 0
  • Target Price
  • IMUX $6.00
  • SHIM N/A
  • AVG Volume (30 Days)
  • IMUX 1.3M
  • SHIM 25.7K
  • Earning Date
  • IMUX 11-13-2025
  • SHIM 11-13-2025
  • Dividend Yield
  • IMUX N/A
  • SHIM N/A
  • EPS Growth
  • IMUX N/A
  • SHIM N/A
  • EPS
  • IMUX N/A
  • SHIM N/A
  • Revenue
  • IMUX N/A
  • SHIM $495,984,000.00
  • Revenue This Year
  • IMUX N/A
  • SHIM $5.42
  • Revenue Next Year
  • IMUX N/A
  • SHIM $6.67
  • P/E Ratio
  • IMUX N/A
  • SHIM N/A
  • Revenue Growth
  • IMUX N/A
  • SHIM N/A
  • 52 Week Low
  • IMUX $0.56
  • SHIM $1.30
  • 52 Week High
  • IMUX $1.42
  • SHIM $3.78
  • Technical
  • Relative Strength Index (RSI)
  • IMUX 47.49
  • SHIM 42.07
  • Support Level
  • IMUX $0.67
  • SHIM $2.01
  • Resistance Level
  • IMUX $0.79
  • SHIM $2.76
  • Average True Range (ATR)
  • IMUX 0.05
  • SHIM 0.19
  • MACD
  • IMUX 0.00
  • SHIM 0.02
  • Stochastic Oscillator
  • IMUX 64.28
  • SHIM 25.31

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

About SHIM Shimmick Corporation

Shimmick Corp is a provider of water and other critical infrastructure solutions nationwide. It selectively focuses on the following types of infrastructure projects: Water Treatment, Water Resources, and Other Critical Infrastructure. In water treatment projects the company expands, rehabilitates, upgrades, builds and rebuilds water and wastewater treatment infrastructure, including desalination plants. In water resources projects company builds, expands, and improves water storage and conveyance, dams, levees, flood control systems, pump stations, and coastal protection. In Other Critical Infrastructure projects, It builds, retrofits, expands, rehabilitates, operates, and maintains its nation's critical infrastructure, including mass transit, bridges, and military infrastructure.

Share on Social Networks: